Cargando…
Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment
The COVID-19 pandemic has significantly impacted the way of life worldwide and continues to bring high mortality rates to at-risk groups. Patients who develop severe COVID-19 pneumonia, often complicated with ARDS, are left with limited treatment options with no targeted therapy currently available....
Autores principales: | Primorac, Dragan, Čemerin, Martin, Matišić, Vid, Molnar, Vilim, Strbad, Marko, Girandon, Lenart, Zenić, Lucija, Knežević, Miomir, Minger, Stephen, Polančec, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469913/ https://www.ncbi.nlm.nih.gov/pubmed/34575557 http://dx.doi.org/10.3390/pharmaceutics13091481 |
Ejemplares similares
-
Compassionate mesenchymal stem cell treatment in a severe COVID-19 patient: a case report
por: Primorac, Dragan, et al.
Publicado: (2021) -
Medicinal signaling cells niche in stromal vascular fraction from lipoaspirate and microfragmented counterpart
por: Zenić, Lucija, et al.
Publicado: (2022) -
Polychromatic Flow Cytometric Analysis of Stromal Vascular Fraction from Lipoaspirate and Microfragmented Counterparts Reveals Sex-Related Immunophenotype Differences
por: Zenic, Lucija, et al.
Publicado: (2021) -
Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review
por: Molnar, Vilim, et al.
Publicado: (2022) -
Mesenchymal Stem Cells Based Treatment in Dental Medicine: A Narrative Review
por: Smojver, Igor, et al.
Publicado: (2022)